The Brazilian policy of withholding treatment for ADHD is probably increasing health and social costs
AUTOR(ES)
Maia, Carlos R., Stella, Steffan F., Mattos, Paulo, Polanczyk, Guilherme V., Polanczyk, Carisi A., Rohde, Luis A.
FONTE
Rev. Bras. Psiquiatr.
DATA DE PUBLICAÇÃO
2015-03
RESUMO
Objective: To estimate the economic consequences of the current Brazilian government policy for attention-deficit/hyperactivity disorder (ADHD) treatment and how much the country would save if treatment with immediate-release methylphenidate (MPH-IR), as suggested by the World Health Organization (WHO), was offered to patients with ADHD. Method: Based on conservative previous analyses, we assumed that 257,662 patients aged 5 to 19 years are not receiving ADHD treatment in Brazil. We estimated the direct costs and savings of treating and not treating ADHD on the basis of the following data: a) spending on ADHD patients directly attributable to grade retention and emergency department visits; and b) savings due to impact of ADHD treatment on these outcomes. Results: Considering outcomes for which data on the impact of MPH-IR treatment are available, Brazil is probably wasting approximately R$ 1.841 billion/year on the direct consequences of not treating ADHD in this age range alone. On the other hand, treating ADHD in accordance with WHO recommendations would save approximately R$ 1.163 billion/year. Conclusions: By increasing investments on MPH-IR treatment for ADHD to around R$ 377 million/year, the country would save approximately 3.1 times more than is currently spent on the consequences of not treating ADHD in patients aged 5 to 19 years.
Documentos Relacionados
- Increasing costs from bladder cancer in the Brazilian Health System: the role of establishing public health policies
- A social policy for health.
- A feasible policy for increasing health services in a community.
- Assessing Genetic Risks: Implications for Health and Social Policy
- Towards guidelines for withholding and withdrawal of life prolonging treatment in neonatal medicine.